Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa5
|
ENSMUSG00000038253.6 | homeobox A5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52204413_52204627 | Hoxa5 | 67 | 0.892002 | -0.26 | 5.4e-02 | Click! |
chr6_52203796_52203947 | Hoxa5 | 716 | 0.315490 | 0.17 | 2.3e-01 | Click! |
chr6_52204014_52204316 | Hoxa5 | 422 | 0.535251 | -0.07 | 6.4e-01 | Click! |
chr6_52204637_52204889 | Hoxa5 | 176 | 0.807489 | -0.06 | 6.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_83985066_83985623 | 39.04 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr12_3236518_3237725 | 27.50 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr9_41697271_41698297 | 27.43 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr16_77291582_77292053 | 24.49 |
Gm31258 |
predicted gene, 31258 |
13743 |
0.19 |
chr8_34326259_34326892 | 23.80 |
Gm4889 |
predicted gene 4889 |
1335 |
0.32 |
chr4_90437683_90437870 | 23.51 |
Gm12635 |
predicted gene 12635 |
15098 |
0.24 |
chr13_83714747_83715651 | 22.96 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6182 |
0.14 |
chr12_25871193_25871842 | 21.55 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr17_51536754_51537055 | 20.55 |
Gm31143 |
predicted gene, 31143 |
2046 |
0.39 |
chr6_66399474_66399715 | 20.53 |
Gm44233 |
predicted gene, 44233 |
848 |
0.4 |
chr5_111195506_111196004 | 20.27 |
Gm43676 |
predicted gene 43676 |
1385 |
0.43 |
chr19_15200549_15200700 | 19.91 |
Gm5513 |
predicted pseudogene 5513 |
239858 |
0.02 |
chr3_139885937_139886924 | 19.72 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr13_89797795_89798023 | 19.69 |
Vcan |
versican |
55400 |
0.13 |
chr14_64200090_64200531 | 18.95 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
83996 |
0.07 |
chrX_157051721_157051918 | 18.79 |
Gm22666 |
predicted gene, 22666 |
2136 |
0.38 |
chrX_49124760_49125142 | 18.61 |
Gm15034 |
predicted gene 15034 |
33272 |
0.17 |
chr14_13651648_13651848 | 18.55 |
Sntn |
sentan, cilia apical structure protein |
19128 |
0.24 |
chr5_85571496_85571691 | 18.37 |
Gm43567 |
predicted gene 43567 |
149181 |
0.05 |
chr7_75983169_75983876 | 18.30 |
Gm45139 |
predicted gene 45139 |
17302 |
0.24 |
chr13_84571911_84572094 | 18.20 |
Gm26913 |
predicted gene, 26913 |
118939 |
0.06 |
chr12_51002470_51002650 | 17.90 |
Gm40421 |
predicted gene, 40421 |
2313 |
0.29 |
chr1_57218074_57218376 | 17.88 |
BC055402 |
cDNA sequence BC055402 |
3232 |
0.3 |
chr5_97289441_97289719 | 17.78 |
Gm5560 |
predicted pseudogene 5560 |
24752 |
0.17 |
chr7_73917720_73918558 | 17.78 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr2_48539077_48539409 | 17.76 |
Gm13481 |
predicted gene 13481 |
81998 |
0.1 |
chr2_153425549_153426538 | 17.64 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr3_70482618_70482822 | 17.29 |
Gm6631 |
predicted gene 6631 |
69401 |
0.12 |
chrX_143654722_143655126 | 17.16 |
Pak3 |
p21 (RAC1) activated kinase 3 |
9366 |
0.3 |
chr3_16431647_16431999 | 17.09 |
Ythdf3 |
YTH N6-methyladenosine RNA binding protein 3 |
248587 |
0.02 |
chr8_125569269_125570645 | 16.95 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr4_24429638_24429836 | 16.86 |
Gm27243 |
predicted gene 27243 |
1153 |
0.54 |
chr3_88206531_88206915 | 16.82 |
Gm3764 |
predicted gene 3764 |
90 |
0.91 |
chr16_91140532_91140860 | 16.80 |
Gm49612 |
predicted gene, 49612 |
5220 |
0.12 |
chr14_98108869_98109062 | 16.76 |
Gm16331 |
predicted gene 16331 |
9544 |
0.27 |
chr9_90693284_90693632 | 16.73 |
Gm2497 |
predicted gene 2497 |
40066 |
0.15 |
chr16_42269181_42269368 | 16.72 |
Gap43 |
growth associated protein 43 |
6798 |
0.24 |
chr5_149513472_149514426 | 16.69 |
Gm2566 |
predicted gene 2566 |
10897 |
0.13 |
chr17_65742516_65742902 | 16.64 |
Rab31 |
RAB31, member RAS oncogene family |
29931 |
0.15 |
chr1_58046960_58047141 | 16.57 |
Aox1 |
aldehyde oxidase 1 |
17086 |
0.16 |
chr4_24429061_24429567 | 16.40 |
Gm27243 |
predicted gene 27243 |
1576 |
0.43 |
chr14_104538063_104538407 | 16.39 |
Rnf219 |
ring finger protein 219 |
15590 |
0.18 |
chr3_17789514_17789745 | 16.37 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
292 |
0.9 |
chr14_34969519_34969852 | 16.35 |
Mir346 |
microRNA 346 |
75076 |
0.11 |
chr5_85240429_85240783 | 16.21 |
Gm21006 |
predicted gene, 21006 |
373761 |
0.01 |
chr2_128331322_128331682 | 16.18 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
197 |
0.96 |
chr5_26991582_26992107 | 16.12 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr7_51772497_51772673 | 15.98 |
Gm29296 |
predicted gene 29296 |
141 |
0.96 |
chr3_6183428_6183711 | 15.95 |
Gm6162 |
predicted gene 6162 |
15745 |
0.23 |
chrX_152656185_152656553 | 15.87 |
Shroom2 |
shroom family member 2 |
11826 |
0.22 |
chr16_74375804_74375965 | 15.81 |
Mir691 |
microRNA 691 |
33817 |
0.18 |
chr15_25291323_25291712 | 15.80 |
4930445E18Rik |
RIKEN cDNA 4930445E18 gene |
41131 |
0.13 |
chr4_31612895_31613222 | 15.79 |
Gm11922 |
predicted gene 11922 |
232586 |
0.02 |
chr9_37359459_37360109 | 15.73 |
Hepacam |
hepatocyte cell adhesion molecule |
7567 |
0.11 |
chr13_31408869_31409060 | 15.64 |
G630018N14Rik |
RIKEN cDNA G630018N14 gene |
42 |
0.97 |
chr6_18445762_18446079 | 15.64 |
Gm26233 |
predicted gene, 26233 |
3420 |
0.21 |
chr4_110287470_110287673 | 15.62 |
Elavl4 |
ELAV like RNA binding protein 4 |
44 |
0.99 |
chr9_45663374_45663610 | 15.58 |
Dscaml1 |
DS cell adhesion molecule like 1 |
9345 |
0.19 |
chr10_39133560_39134579 | 15.57 |
Tube1 |
tubulin, epsilon 1 |
1 |
0.66 |
chrX_140456238_140456679 | 15.50 |
Prps1 |
phosphoribosyl pyrophosphate synthetase 1 |
155 |
0.96 |
chr13_78181182_78181614 | 15.38 |
Gm38604 |
predicted gene, 38604 |
1761 |
0.26 |
chr4_13599724_13600127 | 15.33 |
Gm11825 |
predicted gene 11825 |
6109 |
0.25 |
chr17_56472537_56473329 | 15.30 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr13_84566588_84566757 | 15.26 |
Gm26913 |
predicted gene, 26913 |
124269 |
0.06 |
chr16_77239477_77239636 | 15.22 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
3237 |
0.3 |
chr16_46848064_46848427 | 15.18 |
Gm6912 |
predicted gene 6912 |
225953 |
0.02 |
chr10_17074449_17074835 | 15.06 |
Gm20125 |
predicted gene, 20125 |
11651 |
0.26 |
chrX_102081931_102082285 | 15.05 |
Nhsl2 |
NHS-like 2 |
9166 |
0.13 |
chr14_123513080_123513404 | 15.00 |
Nalcn |
sodium leak channel, non-selective |
113634 |
0.06 |
chr3_156633019_156633200 | 14.94 |
Gm42946 |
predicted gene 42946 |
13211 |
0.21 |
chr5_95991506_95991944 | 14.90 |
Gm7993 |
predicted gene 7993 |
17485 |
0.2 |
chrX_169837979_169838285 | 14.89 |
Mid1 |
midline 1 |
9973 |
0.25 |
chr13_83988136_83988456 | 14.88 |
Gm4241 |
predicted gene 4241 |
305 |
0.91 |
chr1_81594178_81594459 | 14.84 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr16_85092305_85093056 | 14.81 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr1_33201654_33201876 | 14.78 |
Gm24901 |
predicted gene, 24901 |
9772 |
0.17 |
chr7_79535477_79536145 | 14.77 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chrX_58155976_58156127 | 14.76 |
Gm14649 |
predicted gene 14649 |
28435 |
0.21 |
chr18_13896425_13897019 | 14.74 |
Gm50094 |
predicted gene, 50094 |
6748 |
0.26 |
chr5_16134186_16134593 | 14.73 |
Gm43490 |
predicted gene 43490 |
27260 |
0.22 |
chr2_91399567_91399718 | 14.66 |
Gm22071 |
predicted gene, 22071 |
7494 |
0.17 |
chr6_91324837_91325054 | 14.62 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
40126 |
0.12 |
chr2_109673868_109674486 | 14.61 |
Bdnf |
brain derived neurotrophic factor |
523 |
0.63 |
chr2_45227313_45227464 | 14.56 |
Gm28643 |
predicted gene 28643 |
70463 |
0.11 |
chr13_8333561_8334203 | 14.55 |
Gm48260 |
predicted gene, 48260 |
34739 |
0.14 |
chr2_76532502_76532801 | 14.50 |
Osbpl6 |
oxysterol binding protein-like 6 |
15689 |
0.21 |
chr19_15502585_15502938 | 14.50 |
Gm24319 |
predicted gene, 24319 |
177243 |
0.03 |
chr3_18454033_18454237 | 14.47 |
Gm30667 |
predicted gene, 30667 |
7119 |
0.22 |
chr1_42693315_42693672 | 14.44 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
340 |
0.76 |
chr4_131014908_131015145 | 14.42 |
A930031H19Rik |
RIKEN cDNA A930031H19 gene |
4552 |
0.24 |
chr12_49945277_49945719 | 14.38 |
Gm7481 |
predicted gene 7481 |
103747 |
0.08 |
chr11_71750409_71750794 | 14.38 |
Wscd1 |
WSC domain containing 1 |
84 |
0.97 |
chr10_33623806_33623994 | 14.34 |
Clvs2 |
clavesin 2 |
296 |
0.52 |
chr11_40624217_40624397 | 14.30 |
Gm12137 |
predicted gene 12137 |
11589 |
0.19 |
chr7_37337237_37337462 | 14.19 |
6720469O03Rik |
RIKEN cDNA 6720469O03 gene |
29281 |
0.19 |
chr9_29802879_29803476 | 14.18 |
Ntm |
neurotrimin |
159942 |
0.04 |
chrX_61154998_61155204 | 14.16 |
Gm24396 |
predicted gene, 24396 |
9739 |
0.16 |
chr18_26941530_26941727 | 14.12 |
Gm26106 |
predicted gene, 26106 |
13299 |
0.22 |
chr10_108701744_108702064 | 14.10 |
Gm5136 |
predicted gene 5136 |
1744 |
0.46 |
chr9_40268412_40269319 | 14.04 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr16_77852087_77852674 | 14.01 |
Gm17333 |
predicted gene, 17333 |
5776 |
0.27 |
chr14_123065129_123065306 | 14.00 |
AA536875 |
expressed sequence AA536875 |
21935 |
0.22 |
chr8_55121794_55122373 | 13.98 |
Gm8734 |
predicted gene 8734 |
40368 |
0.14 |
chr8_26677560_26678005 | 13.95 |
Gm32098 |
predicted gene, 32098 |
9476 |
0.18 |
chr2_107935313_107935699 | 13.94 |
Gm23439 |
predicted gene, 23439 |
48867 |
0.19 |
chr10_125175367_125175548 | 13.94 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
133359 |
0.05 |
chr14_62637904_62638380 | 13.93 |
Gm23816 |
predicted gene, 23816 |
3049 |
0.2 |
chr7_96718538_96719200 | 13.93 |
Tenm4 |
teneurin transmembrane protein 4 |
59065 |
0.11 |
chr12_12871395_12871578 | 13.88 |
Gm48187 |
predicted gene, 48187 |
5916 |
0.16 |
chr16_77236959_77237505 | 13.87 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
913 |
0.66 |
chr13_39823948_39824404 | 13.85 |
A230103O09Rik |
RIKEN cDNA A230103O09 gene |
178 |
0.94 |
chr16_42275988_42276211 | 13.79 |
Gap43 |
growth associated protein 43 |
27 |
0.98 |
chr3_69709128_69709981 | 13.78 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
7839 |
0.17 |
chr12_56004549_56004776 | 13.77 |
Gm5183 |
predicted gene 5183 |
45871 |
0.13 |
chr14_63586397_63586582 | 13.76 |
Xkr6 |
X-linked Kx blood group related 6 |
20014 |
0.15 |
chr8_9976771_9977424 | 13.75 |
Lig4 |
ligase IV, DNA, ATP-dependent |
589 |
0.43 |
chr4_81566663_81566975 | 13.67 |
Gm11765 |
predicted gene 11765 |
105087 |
0.07 |
chr14_29204763_29204914 | 13.65 |
Gm6043 |
predicted gene 6043 |
12801 |
0.21 |
chr16_43800088_43800449 | 13.58 |
Gm25996 |
predicted gene, 25996 |
2851 |
0.23 |
chr8_86961518_86961711 | 13.57 |
Gm24781 |
predicted gene, 24781 |
4005 |
0.19 |
chr2_179522227_179522422 | 13.56 |
Cdh4 |
cadherin 4 |
78091 |
0.1 |
chr4_64148922_64149333 | 13.55 |
8030451A03Rik |
RIKEN cDNA 8030451A03 gene |
574 |
0.83 |
chr5_16166108_16166523 | 13.55 |
Gm43490 |
predicted gene 43490 |
59186 |
0.14 |
chr12_51002047_51002408 | 13.51 |
Gm40421 |
predicted gene, 40421 |
2646 |
0.28 |
chr1_168549901_168550223 | 13.48 |
Mir6348 |
microRNA 6348 |
59419 |
0.15 |
chr2_72426764_72427187 | 13.47 |
Cdca7 |
cell division cycle associated 7 |
49184 |
0.13 |
chr13_67128044_67128752 | 13.47 |
Zfp759 |
zinc finger protein 759 |
170 |
0.88 |
chr13_83741584_83742060 | 13.46 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2959 |
0.16 |
chr11_4803093_4803266 | 13.46 |
Nf2 |
neurofibromin 2 |
12061 |
0.17 |
chr10_95619676_95619912 | 13.42 |
Gm33336 |
predicted gene, 33336 |
12445 |
0.13 |
chr2_142334870_142335066 | 13.41 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
158361 |
0.04 |
chr6_25437965_25438240 | 13.40 |
Gm22529 |
predicted gene, 22529 |
238051 |
0.02 |
chr11_6606254_6606619 | 13.37 |
Nacad |
NAC alpha domain containing |
383 |
0.7 |
chr11_47264719_47264940 | 13.34 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
114693 |
0.07 |
chr5_97289764_97289960 | 13.34 |
Gm5560 |
predicted pseudogene 5560 |
25034 |
0.17 |
chr6_24201035_24201450 | 13.33 |
Slc13a1 |
solute carrier family 13 (sodium/sulfate symporters), member 1 |
33150 |
0.18 |
chr4_124477930_124478345 | 13.32 |
1700057H15Rik |
RIKEN cDNA 1700057H15 gene |
7822 |
0.23 |
chr10_29143863_29144732 | 13.31 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr3_156301250_156301401 | 13.28 |
Gm42886 |
predicted gene 42886 |
36739 |
0.22 |
chr1_18758436_18758855 | 13.28 |
Gm5252 |
predicted gene 5252 |
50217 |
0.18 |
chr8_47242449_47242654 | 13.27 |
Stox2 |
storkhead box 2 |
135 |
0.97 |
chr4_23636552_23636896 | 13.25 |
Gm25978 |
predicted gene, 25978 |
9979 |
0.24 |
chr10_38553865_38554067 | 13.25 |
Gm22911 |
predicted gene, 22911 |
61515 |
0.14 |
chr4_71230496_71230834 | 13.19 |
Gm11229 |
predicted gene 11229 |
55277 |
0.16 |
chr2_22029338_22029851 | 13.18 |
Gm13337 |
predicted gene 13337 |
38232 |
0.22 |
chr11_43270024_43270232 | 13.16 |
Gm12146 |
predicted gene 12146 |
10344 |
0.19 |
chr1_165075654_165075860 | 13.15 |
4930568G15Rik |
RIKEN cDNA 4930568G15 gene |
7643 |
0.19 |
chr14_14347096_14348750 | 13.14 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr18_77181220_77181592 | 13.13 |
St8sia5 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
4433 |
0.2 |
chr3_62348500_62348904 | 13.13 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
7601 |
0.24 |
chr4_71131009_71131663 | 13.12 |
Gm11228 |
predicted gene 11228 |
203 |
0.96 |
chr1_41814359_41814918 | 13.12 |
Gm29260 |
predicted gene 29260 |
32830 |
0.25 |
chr4_117379821_117380196 | 13.03 |
Rnf220 |
ring finger protein 220 |
4551 |
0.2 |
chr1_165076116_165076288 | 12.97 |
4930568G15Rik |
RIKEN cDNA 4930568G15 gene |
8088 |
0.19 |
chr5_65130986_65131181 | 12.96 |
Klhl5 |
kelch-like 5 |
7 |
0.97 |
chr1_23575152_23575373 | 12.93 |
Gm28822 |
predicted gene 28822 |
675 |
0.79 |
chr13_59092007_59092498 | 12.93 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
8159 |
0.17 |
chr13_28416227_28416775 | 12.91 |
Gm40841 |
predicted gene, 40841 |
3362 |
0.31 |
chr9_90692777_90692928 | 12.89 |
Gm2497 |
predicted gene 2497 |
40672 |
0.14 |
chr14_11960906_11961113 | 12.87 |
Gm3848 |
predicted gene 3848 |
20199 |
0.22 |
chr12_29871996_29872873 | 12.87 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr13_8484564_8485187 | 12.86 |
Gm48262 |
predicted gene, 48262 |
68145 |
0.12 |
chr2_118203496_118203665 | 12.85 |
Gm22800 |
predicted gene, 22800 |
45202 |
0.1 |
chr17_66869624_66870037 | 12.84 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr3_114029993_114030781 | 12.83 |
Col11a1 |
collagen, type XI, alpha 1 |
153 |
0.98 |
chr3_35088285_35088679 | 12.77 |
Mir6378 |
microRNA 6378 |
165831 |
0.03 |
chr6_45544302_45544926 | 12.73 |
Gm43876 |
predicted gene, 43876 |
15531 |
0.27 |
chr13_15741859_15742225 | 12.71 |
Gm48408 |
predicted gene, 48408 |
28078 |
0.16 |
chr8_36142092_36142588 | 12.69 |
Gm38414 |
predicted gene, 38414 |
13670 |
0.15 |
chr16_64068866_64069083 | 12.69 |
Gm49627 |
predicted gene, 49627 |
113844 |
0.07 |
chr6_16317109_16317303 | 12.68 |
Gm3148 |
predicted gene 3148 |
79579 |
0.1 |
chr13_51580731_51580926 | 12.66 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
11341 |
0.21 |
chr9_41078112_41078514 | 12.66 |
Ubash3b |
ubiquitin associated and SH3 domain containing, B |
1193 |
0.46 |
chr12_12938393_12939271 | 12.59 |
Mycn |
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
1784 |
0.26 |
chr1_78167977_78168321 | 12.59 |
Pax3 |
paired box 3 |
28689 |
0.2 |
chr3_39047740_39047911 | 12.58 |
Gm43539 |
predicted gene 43539 |
38144 |
0.19 |
chr3_34104007_34104173 | 12.57 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
180 |
0.93 |
chr13_83984413_83984945 | 12.56 |
Gm4241 |
predicted gene 4241 |
3312 |
0.25 |
chr4_100597088_100597359 | 12.53 |
Gm12700 |
predicted gene 12700 |
15945 |
0.21 |
chr6_112885019_112885538 | 12.50 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
55819 |
0.1 |
chr8_100516007_100516194 | 12.49 |
Gm45296 |
predicted gene 45296 |
77342 |
0.12 |
chr2_82847422_82847589 | 12.49 |
Fsip2 |
fibrous sheath-interacting protein 2 |
96129 |
0.09 |
chr15_44706767_44707004 | 12.48 |
Sybu |
syntabulin (syntaxin-interacting) |
40903 |
0.15 |
chr14_108914445_108914596 | 12.48 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
362 |
0.93 |
chr9_95814100_95814497 | 12.44 |
Pls1 |
plastin 1 (I-isoform) |
1108 |
0.48 |
chr1_177411101_177411252 | 12.43 |
Gm26801 |
predicted gene, 26801 |
17908 |
0.17 |
chr12_35008006_35008205 | 12.41 |
Prps1l1 |
phosphoribosyl pyrophosphate synthetase 1-like 1 |
23344 |
0.17 |
chr13_6306939_6307331 | 12.41 |
Gm35615 |
predicted gene, 35615 |
12421 |
0.23 |
chr13_28295576_28295772 | 12.38 |
Gm47172 |
predicted gene, 47172 |
10105 |
0.23 |
chr6_52119364_52119515 | 12.33 |
Rps8-ps3 |
ribosomal protein S8, pseudogene 3 |
1197 |
0.26 |
chr16_62468984_62469164 | 12.33 |
CT010569.1 |
NADH dehydrogenase 5, mitochondrial (mt-Nd5) pseudogene |
14875 |
0.27 |
chr7_109165964_109166186 | 12.32 |
Lmo1 |
LIM domain only 1 |
4437 |
0.2 |
chr14_121062242_121062707 | 12.28 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
26910 |
0.23 |
chr7_93062174_93062609 | 12.27 |
Fam181b |
family with sequence similarity 181, member B |
17474 |
0.16 |
chr13_44232185_44232493 | 12.24 |
Gm47781 |
predicted gene, 47781 |
59 |
0.97 |
chr12_48634776_48635069 | 12.24 |
Gm29818 |
predicted gene, 29818 |
2629 |
0.39 |
chr7_70103761_70103947 | 12.23 |
Gm35325 |
predicted gene, 35325 |
103581 |
0.06 |
chr7_130216444_130216595 | 12.22 |
Fgfr2 |
fibroblast growth factor receptor 2 |
12237 |
0.28 |
chr3_120982893_120983085 | 12.18 |
Gm43444 |
predicted gene 43444 |
37787 |
0.16 |
chr12_12220796_12221120 | 12.14 |
Fam49a |
family with sequence similarity 49, member A |
41181 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.4 | 85.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
11.4 | 34.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
10.7 | 42.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
9.8 | 29.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
9.1 | 64.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
9.0 | 63.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
6.6 | 26.3 | GO:0007412 | axon target recognition(GO:0007412) |
6.5 | 19.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
6.1 | 18.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
5.8 | 17.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
5.7 | 17.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
5.7 | 34.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
5.5 | 27.7 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
5.5 | 16.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
5.4 | 16.1 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
5.4 | 10.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
5.2 | 20.9 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
5.2 | 15.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
5.1 | 133.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
4.9 | 19.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
4.8 | 9.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
4.8 | 33.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
4.7 | 14.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
4.7 | 14.0 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
4.5 | 9.0 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
4.5 | 13.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
4.5 | 18.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
4.5 | 17.8 | GO:0061743 | motor learning(GO:0061743) |
4.3 | 17.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
4.3 | 8.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
4.1 | 8.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
4.0 | 8.0 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
4.0 | 4.0 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
4.0 | 19.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
3.9 | 15.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
3.8 | 19.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
3.8 | 11.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
3.8 | 3.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
3.8 | 11.3 | GO:0030070 | insulin processing(GO:0030070) |
3.8 | 15.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.7 | 11.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.7 | 11.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.6 | 7.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
3.6 | 14.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
3.6 | 10.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.6 | 14.2 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
3.5 | 21.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
3.5 | 7.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.5 | 24.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.4 | 24.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
3.4 | 24.1 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
3.4 | 6.8 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
3.4 | 6.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.4 | 13.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
3.3 | 30.1 | GO:0071625 | vocalization behavior(GO:0071625) |
3.2 | 15.8 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
3.2 | 6.3 | GO:0060166 | olfactory pit development(GO:0060166) |
3.1 | 9.4 | GO:0097503 | sialylation(GO:0097503) |
3.1 | 81.1 | GO:0001964 | startle response(GO:0001964) |
3.1 | 6.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
3.0 | 6.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
3.0 | 9.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
2.9 | 8.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
2.9 | 2.9 | GO:0060594 | mammary gland specification(GO:0060594) |
2.9 | 5.7 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
2.8 | 5.7 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
2.8 | 17.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
2.8 | 5.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.8 | 8.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.8 | 5.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
2.8 | 11.1 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.8 | 22.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.8 | 2.8 | GO:0021586 | pons maturation(GO:0021586) |
2.7 | 8.1 | GO:0001757 | somite specification(GO:0001757) |
2.7 | 2.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
2.7 | 5.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.7 | 13.5 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.7 | 8.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
2.7 | 8.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
2.7 | 8.0 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
2.6 | 5.3 | GO:0021564 | vagus nerve development(GO:0021564) |
2.6 | 10.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.6 | 15.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.6 | 7.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.6 | 2.6 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.6 | 7.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.5 | 10.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
2.5 | 2.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.5 | 7.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.5 | 12.3 | GO:0019532 | oxalate transport(GO:0019532) |
2.5 | 12.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
2.5 | 2.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
2.5 | 46.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.4 | 7.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
2.4 | 2.4 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
2.4 | 4.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.4 | 4.8 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
2.4 | 9.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.4 | 7.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.4 | 4.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
2.4 | 28.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.4 | 127.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.3 | 4.6 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
2.3 | 2.3 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.3 | 2.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
2.2 | 11.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
2.2 | 15.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
2.2 | 4.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.2 | 19.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.2 | 169.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
2.2 | 2.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.2 | 6.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
2.2 | 6.5 | GO:0001927 | exocyst assembly(GO:0001927) |
2.1 | 10.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.1 | 6.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.1 | 6.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.1 | 4.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.1 | 4.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
2.1 | 10.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
2.1 | 35.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.1 | 4.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.1 | 8.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
2.0 | 6.1 | GO:0060005 | vestibular reflex(GO:0060005) |
2.0 | 4.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
2.0 | 8.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.0 | 8.0 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
2.0 | 8.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
2.0 | 4.0 | GO:0061055 | myotome development(GO:0061055) |
2.0 | 13.9 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.0 | 15.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.0 | 9.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.0 | 13.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.0 | 5.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.9 | 3.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.9 | 5.8 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
1.9 | 1.9 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.9 | 11.4 | GO:0035989 | tendon development(GO:0035989) |
1.9 | 7.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.9 | 19.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.9 | 3.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.9 | 7.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.9 | 11.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.9 | 5.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.9 | 7.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.8 | 9.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.8 | 8.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.8 | 7.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.8 | 7.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.8 | 5.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.7 | 8.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.7 | 7.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.7 | 1.7 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.7 | 8.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
1.7 | 5.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.7 | 3.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.7 | 3.4 | GO:0015755 | fructose transport(GO:0015755) |
1.7 | 6.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.7 | 3.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.7 | 1.7 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.7 | 5.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.7 | 5.0 | GO:0060437 | lung growth(GO:0060437) |
1.6 | 3.3 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.6 | 3.3 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.6 | 4.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.6 | 4.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.6 | 3.2 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
1.6 | 1.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.6 | 1.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.6 | 4.8 | GO:0061511 | centriole elongation(GO:0061511) |
1.6 | 6.3 | GO:0070842 | aggresome assembly(GO:0070842) |
1.6 | 11.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.6 | 4.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.6 | 4.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.6 | 11.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.6 | 7.8 | GO:0022038 | corpus callosum development(GO:0022038) |
1.6 | 4.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.5 | 3.1 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
1.5 | 15.3 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
1.5 | 4.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.5 | 3.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.5 | 3.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.5 | 1.5 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.5 | 1.5 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.5 | 9.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.5 | 1.5 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.5 | 3.0 | GO:0003139 | secondary heart field specification(GO:0003139) |
1.5 | 3.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.5 | 4.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.5 | 10.4 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.5 | 5.9 | GO:0030091 | protein repair(GO:0030091) |
1.5 | 4.4 | GO:0045760 | positive regulation of action potential(GO:0045760) |
1.5 | 3.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.5 | 5.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.4 | 4.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.4 | 4.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.4 | 1.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.4 | 5.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.4 | 9.8 | GO:0006108 | malate metabolic process(GO:0006108) |
1.4 | 16.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.4 | 4.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.4 | 1.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.4 | 2.7 | GO:0090135 | actin filament branching(GO:0090135) |
1.3 | 2.7 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
1.3 | 1.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.3 | 1.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.3 | 10.7 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.3 | 14.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.3 | 4.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
1.3 | 6.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.3 | 4.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.3 | 4.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.3 | 2.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.3 | 1.3 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
1.3 | 3.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.3 | 5.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.3 | 6.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.3 | 3.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.3 | 14.0 | GO:0003334 | keratinocyte development(GO:0003334) |
1.3 | 8.9 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.3 | 5.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.3 | 6.3 | GO:0060179 | male mating behavior(GO:0060179) |
1.3 | 17.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.3 | 2.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.2 | 1.2 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.2 | 7.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.2 | 3.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.2 | 5.0 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 3.7 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.2 | 2.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.2 | 1.2 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
1.2 | 3.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.2 | 4.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.2 | 2.4 | GO:0008038 | neuron recognition(GO:0008038) |
1.2 | 2.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 3.5 | GO:0090427 | activation of meiosis(GO:0090427) |
1.2 | 2.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.2 | 3.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.2 | 3.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 5.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.1 | 4.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.1 | 3.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
1.1 | 1.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.1 | 3.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.1 | 6.6 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
1.1 | 2.2 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.1 | 3.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.1 | 4.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.1 | 2.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.1 | 22.6 | GO:0007616 | long-term memory(GO:0007616) |
1.1 | 2.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.1 | 5.3 | GO:0015884 | folic acid transport(GO:0015884) |
1.1 | 1.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.1 | 1.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.1 | 2.1 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
1.1 | 8.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
1.0 | 7.3 | GO:0006983 | ER overload response(GO:0006983) |
1.0 | 4.1 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
1.0 | 6.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.0 | 4.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.0 | 8.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.0 | 3.1 | GO:1902896 | terminal web assembly(GO:1902896) |
1.0 | 5.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
1.0 | 5.1 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.0 | 3.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.0 | 4.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.0 | 3.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.0 | 5.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.0 | 5.0 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.0 | 1.0 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.0 | 5.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
1.0 | 3.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
1.0 | 21.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
1.0 | 2.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.0 | 3.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.0 | 2.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.0 | 3.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.0 | 5.8 | GO:0048840 | otolith development(GO:0048840) |
1.0 | 1.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.0 | 2.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.9 | 2.8 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.9 | 1.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.9 | 3.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.9 | 9.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.9 | 14.0 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.9 | 2.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.9 | 2.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.9 | 11.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.9 | 1.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.9 | 2.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.9 | 6.4 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.9 | 1.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.9 | 0.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.9 | 4.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.9 | 7.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.9 | 2.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.9 | 0.9 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.9 | 3.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.9 | 0.9 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.9 | 1.8 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 1.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 3.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.9 | 6.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.9 | 12.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 9.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 2.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.9 | 1.7 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.9 | 4.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.9 | 1.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.8 | 1.7 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.8 | 3.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.8 | 1.7 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 13.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.8 | 1.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.8 | 7.3 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.8 | 0.8 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.8 | 3.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.8 | 2.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.8 | 1.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.8 | 1.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.8 | 10.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.8 | 2.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 7.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.8 | 2.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 2.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 2.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.8 | 1.6 | GO:0046959 | habituation(GO:0046959) |
0.8 | 3.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.8 | 8.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.8 | 2.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.8 | 15.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.8 | 3.8 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.8 | 0.8 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.8 | 1.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.7 | 2.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 0.7 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.7 | 5.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 2.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.7 | 0.7 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.7 | 1.5 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.7 | 2.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 8.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.7 | 0.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.7 | 6.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.7 | 1.4 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.7 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.7 | 6.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.7 | 1.4 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.7 | 2.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.7 | 2.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.7 | 2.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 1.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 11.7 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.7 | 3.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.7 | 3.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 7.4 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.7 | 1.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.7 | 1.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 8.0 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.7 | 18.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.7 | 2.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.7 | 3.3 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.7 | 3.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.6 | 0.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.6 | 1.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 1.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.6 | 3.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.6 | 2.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.6 | 2.6 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.6 | 3.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 2.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.6 | 1.9 | GO:0031296 | B cell costimulation(GO:0031296) |
0.6 | 8.8 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.6 | 5.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.6 | 3.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.6 | 2.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.6 | 8.0 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.6 | 0.6 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.6 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 6.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.6 | 1.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 1.8 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.6 | 0.6 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.6 | 5.9 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.6 | 1.8 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.6 | 3.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.6 | 4.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.6 | 0.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.6 | 1.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 1.8 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 5.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 1.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 1.7 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.6 | 0.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 2.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.6 | 0.6 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.6 | 1.7 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 1.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.6 | 6.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.6 | 0.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.6 | 5.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.6 | 2.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.6 | 4.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.6 | 1.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 1.6 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.5 | 2.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 2.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 3.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.5 | 1.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.5 | 8.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.5 | 1.6 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.5 | 3.7 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.5 | 3.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.5 | 1.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.5 | 0.5 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.5 | 3.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 1.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 1.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.5 | 1.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 2.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.5 | 1.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 5.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.5 | 1.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 1.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.5 | 1.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 1.0 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.5 | 1.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 1.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.5 | 28.5 | GO:0007612 | learning(GO:0007612) |
0.5 | 0.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 2.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 1.9 | GO:0007320 | insemination(GO:0007320) |
0.5 | 0.9 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 3.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.5 | 1.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 3.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 1.4 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.5 | 5.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.5 | 0.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 0.9 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.5 | 0.5 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 0.4 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.4 | 0.9 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.4 | 1.3 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.4 | 3.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.4 | 1.8 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.4 | 2.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.4 | 0.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 3.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 0.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 1.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 2.1 | GO:0060384 | innervation(GO:0060384) |
0.4 | 1.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.4 | 1.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 0.8 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.4 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 0.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.4 | 2.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 0.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.4 | 2.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 1.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 1.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 0.8 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 0.4 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.4 | 0.8 | GO:0007567 | parturition(GO:0007567) |
0.4 | 2.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 0.4 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.4 | 1.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.4 | 0.4 | GO:0072207 | metanephric epithelium development(GO:0072207) |
0.4 | 1.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 0.4 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.4 | 1.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 1.9 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 1.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 0.4 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.4 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.4 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.4 | 6.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.4 | 1.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 0.8 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 3.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 0.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.4 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 0.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 6.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 1.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 2.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.4 | 1.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 1.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.4 | 0.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 2.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 0.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 2.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 0.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 1.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 3.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 1.6 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.3 | 1.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 1.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 1.6 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 4.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 1.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 0.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.3 | 1.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.3 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.3 | 0.3 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 0.9 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 2.7 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.3 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 2.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 0.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 1.2 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.3 | 1.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 1.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 2.9 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 1.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 4.0 | GO:0007416 | synapse assembly(GO:0007416) |
0.3 | 0.9 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.9 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 2.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.3 | 2.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 2.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.3 | GO:0046881 | positive regulation of luteinizing hormone secretion(GO:0033686) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 1.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.3 | 1.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 1.5 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.3 | 0.8 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 1.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 1.0 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.2 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.2 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 3.6 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 1.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 1.6 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.2 | 1.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.9 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.9 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 0.4 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.6 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.6 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 1.5 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.9 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 0.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 3.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 1.6 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.2 | 4.5 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.2 | 3.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.3 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.2 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 1.6 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 1.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.6 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.1 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 11.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 4.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 1.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.1 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.1 | 0.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.1 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.2 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 1.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 75.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.9 | 19.4 | GO:0033010 | paranodal junction(GO:0033010) |
4.8 | 14.5 | GO:0072534 | perineuronal net(GO:0072534) |
4.8 | 38.2 | GO:0043083 | synaptic cleft(GO:0043083) |
4.6 | 13.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
4.3 | 12.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
4.0 | 12.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.7 | 25.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
3.7 | 29.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
3.7 | 11.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
3.7 | 18.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.5 | 38.8 | GO:0043194 | axon initial segment(GO:0043194) |
3.5 | 13.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
3.4 | 13.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
3.2 | 54.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.1 | 31.3 | GO:0030673 | axolemma(GO:0030673) |
3.0 | 12.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
3.0 | 47.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.9 | 138.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
2.8 | 11.2 | GO:1990696 | USH2 complex(GO:1990696) |
2.8 | 8.3 | GO:0033269 | internode region of axon(GO:0033269) |
2.8 | 11.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.7 | 16.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.6 | 7.7 | GO:0097441 | basilar dendrite(GO:0097441) |
2.4 | 21.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.3 | 23.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.3 | 13.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.2 | 13.4 | GO:0032584 | growth cone membrane(GO:0032584) |
2.1 | 53.6 | GO:0044295 | axonal growth cone(GO:0044295) |
2.1 | 14.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.1 | 30.9 | GO:0031527 | filopodium membrane(GO:0031527) |
2.0 | 6.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.9 | 3.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.8 | 5.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.7 | 14.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.6 | 3.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.6 | 6.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.6 | 6.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.6 | 9.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
1.6 | 21.9 | GO:0031045 | dense core granule(GO:0031045) |
1.5 | 1.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.5 | 4.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.5 | 63.7 | GO:0043198 | dendritic shaft(GO:0043198) |
1.5 | 5.9 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.5 | 2.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.5 | 23.5 | GO:0005614 | interstitial matrix(GO:0005614) |
1.4 | 4.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.4 | 2.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.4 | 199.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.4 | 4.1 | GO:0036396 | MIS complex(GO:0036396) |
1.3 | 4.0 | GO:0043511 | inhibin complex(GO:0043511) |
1.3 | 6.6 | GO:0044327 | dendritic spine head(GO:0044327) |
1.3 | 2.5 | GO:0033263 | CORVET complex(GO:0033263) |
1.2 | 4.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.2 | 4.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.2 | 9.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.1 | 17.1 | GO:0043205 | fibril(GO:0043205) |
1.1 | 5.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.0 | 4.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.0 | 27.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.0 | 3.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.0 | 15.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 55.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.0 | 7.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 9.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.9 | 5.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.9 | 11.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.9 | 7.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.9 | 2.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.9 | 7.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.9 | 1.7 | GO:0044308 | axonal spine(GO:0044308) |
0.8 | 16.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.8 | 45.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.8 | 2.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 2.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.8 | 8.7 | GO:0042555 | MCM complex(GO:0042555) |
0.8 | 3.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.7 | 4.5 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 3.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 2.9 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 2.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 3.4 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 2.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 2.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 7.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 1.7 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 6.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 33.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 15.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 2.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.5 | 18.4 | GO:0030175 | filopodium(GO:0030175) |
0.5 | 2.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 3.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 3.9 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 5.3 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.5 | 1.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 2.8 | GO:0002177 | manchette(GO:0002177) |
0.5 | 40.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 2.3 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 1.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 3.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 2.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 4.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 3.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 0.4 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.4 | 1.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 25.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.4 | 1.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 2.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 4.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 3.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 2.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 0.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 0.9 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 0.8 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 1.4 | GO:0097433 | dense body(GO:0097433) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 2.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 6.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 1.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 28.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 8.7 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 1.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.7 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 16.0 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.8 | 47.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
12.8 | 38.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
8.8 | 43.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
7.9 | 23.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
7.9 | 31.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
5.8 | 29.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
5.6 | 16.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
5.6 | 38.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
5.3 | 15.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
5.2 | 15.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
5.1 | 20.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
4.5 | 17.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
4.3 | 4.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
4.3 | 30.2 | GO:0003680 | AT DNA binding(GO:0003680) |
4.1 | 20.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
4.1 | 12.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
4.0 | 23.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
4.0 | 7.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
3.8 | 22.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
3.4 | 30.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
3.4 | 13.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
3.2 | 9.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
3.1 | 9.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.1 | 15.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
3.1 | 27.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
3.0 | 57.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
2.9 | 35.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.9 | 5.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.8 | 11.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
2.8 | 16.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.5 | 7.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.5 | 7.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
2.5 | 12.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.4 | 4.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.4 | 12.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.4 | 9.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.4 | 7.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.4 | 9.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
2.4 | 11.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.4 | 11.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
2.3 | 9.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.3 | 11.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.2 | 29.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.2 | 4.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
2.1 | 19.3 | GO:0038191 | neuropilin binding(GO:0038191) |
2.1 | 6.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.1 | 10.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.1 | 6.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.1 | 12.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
2.1 | 18.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.0 | 6.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.0 | 13.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.0 | 6.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
2.0 | 9.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
2.0 | 7.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.9 | 1.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.9 | 5.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.8 | 9.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.8 | 5.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.8 | 9.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.8 | 53.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.8 | 1.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.7 | 17.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
1.7 | 5.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.6 | 4.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.6 | 25.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.6 | 4.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.6 | 4.7 | GO:0043398 | HLH domain binding(GO:0043398) |
1.6 | 1.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.5 | 4.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.5 | 30.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.5 | 4.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.5 | 4.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.5 | 4.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.5 | 5.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.4 | 4.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.4 | 15.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.4 | 8.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.3 | 2.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.3 | 18.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.3 | 25.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.3 | 10.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.3 | 2.5 | GO:0097016 | L27 domain binding(GO:0097016) |
1.2 | 5.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 3.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.2 | 3.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.2 | 6.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.2 | 4.9 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.2 | 3.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.2 | 1.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.2 | 7.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.2 | 14.1 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
1.2 | 2.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.2 | 12.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.2 | 34.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.2 | 4.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.2 | 15.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
1.1 | 4.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.1 | 5.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.1 | 22.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.1 | 6.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.1 | 11.8 | GO:0005522 | profilin binding(GO:0005522) |
1.1 | 5.3 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
1.1 | 5.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.1 | 23.3 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.0 | 23.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.0 | 5.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.0 | 14.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.0 | 11.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.0 | 3.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.0 | 3.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.0 | 3.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.0 | 2.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.0 | 8.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.0 | 4.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.0 | 7.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.9 | 13.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.9 | 2.8 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.9 | 3.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.9 | 6.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.9 | 2.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.9 | 4.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.9 | 8.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 3.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.9 | 2.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.9 | 5.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.9 | 22.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.9 | 2.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 4.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.9 | 20.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.9 | 5.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.9 | 1.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 4.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.9 | 5.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.8 | 4.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.8 | 2.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.8 | 9.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.8 | 3.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.8 | 2.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.8 | 18.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.8 | 2.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 5.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.7 | 2.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.7 | 2.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.7 | 2.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 16.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.7 | 4.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.7 | 2.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.7 | 4.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 8.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 2.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.7 | 3.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.7 | 6.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.7 | 2.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 22.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 3.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.7 | 4.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.7 | 8.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.7 | 2.0 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.7 | 6.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 2.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.6 | 3.2 | GO:0048185 | activin binding(GO:0048185) |
0.6 | 12.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 2.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.6 | 2.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.6 | 6.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 6.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 1.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.6 | 3.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 1.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 1.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 2.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 2.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 5.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.5 | 3.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 23.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.5 | 2.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 2.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 1.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.5 | 1.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 1.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 1.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 1.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 7.8 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 1.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.5 | 5.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.3 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.4 | 22.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.4 | 4.4 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 3.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 1.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.4 | 2.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.4 | 2.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.4 | 6.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 1.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.2 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 1.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 3.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 1.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 4.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 0.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 1.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 11.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 3.9 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 0.7 | GO:0035240 | dopamine binding(GO:0035240) |
0.3 | 1.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 2.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 2.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 2.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 6.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 2.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 8.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.3 | 3.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 1.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 6.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 8.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 3.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 2.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 2.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 3.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.9 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 4.7 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.2 | 0.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 1.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 1.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 2.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 1.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 2.5 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 5.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 4.7 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 2.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 2.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
2.1 | 33.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.9 | 3.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.6 | 48.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.1 | 15.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.0 | 16.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.0 | 17.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.0 | 1.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.9 | 28.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.8 | 16.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 9.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 12.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 15.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 17.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 16.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.5 | 11.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 2.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 5.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 0.9 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 9.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 38.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 3.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 2.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 7.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 5.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 10.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
3.3 | 39.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.3 | 74.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.9 | 41.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.8 | 14.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.5 | 51.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.2 | 2.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
2.2 | 6.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.1 | 23.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.1 | 36.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.0 | 27.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.9 | 28.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.9 | 81.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.8 | 60.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.8 | 3.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.8 | 38.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.7 | 19.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.6 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.5 | 21.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.4 | 25.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.3 | 33.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.1 | 3.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.1 | 13.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.1 | 15.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.0 | 4.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.9 | 0.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.9 | 2.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.8 | 9.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.7 | 6.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 5.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.7 | 12.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.7 | 8.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.7 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.7 | 24.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.7 | 9.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 5.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.6 | 3.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 4.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 0.6 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.6 | 2.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 8.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 12.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 2.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.5 | 4.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.5 | 13.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 11.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 1.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 4.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 6.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.4 | 1.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 5.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 6.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 4.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 4.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 2.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 11.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 4.0 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 1.3 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 1.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 7.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.7 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 2.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 3.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 2.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 5.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.8 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 2.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |